Vioxx might increase the risk of MI

June 2000

Some patients are concerned about the latest news that Vioxx might increase the risk of MI.

This news comes from the recent VIGOR trial...comparing high doses of Vioxx with naproxen for rheumatoid arthritis.

It shows that patients on Vioxx have FEWER GI complications than those on naproxen...but MORE MIs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote